Renaissance Technologies’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-567,400
| Closed | -$493K | – | 4277 |
|
|
2023
Q2 | $493K | Sell |
567,400
-67,600
| -11% | -$48.2K | ﹤0.01% | 2876 |
|
|
2023
Q1 | $444K | Sell |
635,000
-79,155
| -11% | -$64.1K | ﹤0.01% | 2945 |
|
|
2022
Q4 | $586K | Sell |
714,155
-271,188
| -28% | -$267K | ﹤0.01% | 2862 |
|
|
2022
Q3 | $1.02M | Buy |
985,343
+161,653
| +20% | +$258K | ﹤0.01% | 2482 |
|
|
2022
Q2 | $1.35M | Buy |
823,690
+225,062
| +38% | +$467K | ﹤0.01% | 2498 |
|
|
2022
Q1 | $1.76M | Buy |
+598,628
| New | +$2.1M | ﹤0.01% | 2327 |
|
|
2020
Q4 | – | Sell |
-381,737
| Closed | -$2.63M | – | 3810 |
|
|
2020
Q3 | $2.63M | Sell |
381,737
-177,600
| -32% | -$1.08M | ﹤0.01% | 1968 |
|
|
2020
Q2 | $3.67M | Buy |
559,337
+393,995
| +238% | +$1.42M | ﹤0.01% | 1827 |
|
|
2020
Q1 | $309K | Sell |
165,342
-23,758
| -13% | -$62.6K | ﹤0.01% | 2969 |
|
|
2019
Q4 | $356K | Buy |
189,100
+139,900
| +284% | +$233K | ﹤0.01% | 3020 |
|
|
2019
Q3 | $70K | Buy |
49,200
+26,000
| +112% | +$56.8K | ﹤0.01% | 3304 |
|
|
2019
Q2 | $65K | Buy |
+23,200
| New | +$92.4K | ﹤0.01% | 3432 |
|
Renaissance Technologies's SURF Position: Q3 2023 in Review
Renaissance Technologies sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 567,400 shares — an estimated $493K sold.
Renaissance Technologies first reported a position in SURF in Q2 2019 and held it in 12 quarters. The position peaked at $3.67M in Q2 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- Renaissance Technologies reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Renaissance Technologies sold 567,400 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $493K.
- Renaissance Technologies first reported a position in Surface Oncology, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
- Renaissance Technologies's Surface Oncology, Inc. Common Stock position peaked at $3.67M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.